chr1-203217736-TACTC-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 4P and 9B. PVS1_StrongBP6BA1
The ENST00000367229.6(CHIT1):c.1155_1156+2del variant causes a splice donor, coding sequence change. The variant allele was found at a frequency of 0.0045 in 1,613,672 control chromosomes in the GnomAD database, including 264 homozygotes. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L385L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000367229.6 splice_donor, coding_sequence
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHIT1 | NM_003465.3 | c.1155_1156+2del | splice_donor_variant, coding_sequence_variant | 10/11 | ENST00000367229.6 | NP_003456.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHIT1 | ENST00000367229.6 | c.1155_1156+2del | splice_donor_variant, coding_sequence_variant | 10/11 | 1 | NM_003465.3 | ENSP00000356198 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0236 AC: 3586AN: 151944Hom.: 128 Cov.: 33
GnomAD3 exomes AF: 0.00615 AC: 1545AN: 251072Hom.: 57 AF XY: 0.00436 AC XY: 591AN XY: 135694
GnomAD4 exome AF: 0.00250 AC: 3648AN: 1461610Hom.: 135 AF XY: 0.00222 AC XY: 1616AN XY: 727122
GnomAD4 genome AF: 0.0237 AC: 3606AN: 152062Hom.: 129 Cov.: 33 AF XY: 0.0222 AC XY: 1652AN XY: 74320
ClinVar
Submissions by phenotype
Chitotriosidase deficiency Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | The CHIT1 c.1155_1156+2delGAGT variant occurs in a canonical splice site (donor) and is therefore predicted to disrupt or distort the normal gene product. The variant has been reported in one study where CHIT1 genotyping of patients with Gaucher disease was performed to assess possible issues with therapeutic monitoring (Adelino et al. 2012). In this study, the c.1155_1156+2delGAGT variant was found in a one patient with Gaucher disease along with a second missense variant that is known to reduce chitotriosidase enzyme activity. It was noted that this patient also carried a common allele in this gene (duplication of 24 bp in exon 11 of the CHIT1 gene): an allele which is known to lead to an absence of chitotriosidase enzyme activity. The phase of these variants in this individual is unknown. Control data are unavailable for this variant, which is reported at a frequency of 0.12963 in the Yoruba Nigerian population of the 1000 Genomes Project. Based on the potential impact of splice variants and the limited evidence, the c.1155_1156+2delGAGT variant is classified as a variant of unknown significance but suspicious for pathogenicity for chitotriosidase deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 16, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at